Severe perineal hidradenitis suppurativa (HS) and anal fistulas. An underrated association?

Document Type : Brief Report

Authors

1 Consorcio Hospital General Universitario de Valencia

2 Hospital Universitario de La Ribera/Alzira

Abstract

Abstract
Background
Due to its multiple forms of debut hidradenitis suppurativa has classically been a diagnostic challenge as well in the differential diagnosis. Prevalence of perianal fistula in patients with hidradenitis suppurativa ranges form 6,6% to 67%. The aim of the study was to assess both conditions.
Methods
A retrospective chart review from 2000 to 2018 using the ICD-9-CM, coded with 705.83. for patients with hidradenitis suppurativa was conducted. Hurley’s three stage classification was applied. Diagnosis and relevant patient characteristics were assessed and the presence of associated perianal fistula. Endoa-nal ultrasound (EAU) was performed in 61% of the patients with perianal hidradenitis and perianal fistu-la, and magnetic resonance imaging (MRI) in 19%.
Results
Of 143 cases with hidradenitis, sixty two cases (43,4%) presented perianal (perineal/buttocks) location. Of them 93,5% were men. Twenty-one percent were associated with perianal fistulas being 6 of them complex ones associated with Hurley stage II and III. Treatment for the latter included: loose setons in 4 patients with Crohn’s disease and in 2 non Crohn’s disease with complex fistulas, 4 fistulotomies and 2 fistulectomies in low transphincteric fistulas and 1 with incision and drainage.

Conclusion
Perianal fistula should be treated according to associated diseases and type of fistula. Association of hidradenitis and perianal fistulas may be higher than expected and the relation of severe hidradenitis with complex perianal fistulas should be studied further. Endoanal ultrasound and MRI may be useful tools to assess HS with complex perianal fistulas, but the iconographic patterns of hidradenitis and Crohn’s disease should be kept in mind as both may be associated.

Keywords


 
[1] EMA/CHMP/177541/2015. Committee for Medicinal Products for Human Use. Extension of indication variation assessment report.  Invented name: Humeral. Procedure Nº. EMEA/H/C/000481/II/0134 European Medicines Agency. Science Medicines Health. London E14 SEU, United Kingdom.
[2] Iniciativa estratégica de salud para la definición del estándar óptimo de cuidados. Para los pacientes con hidradenitis supurativa. Hércules. Iniciativa estratégica en hidradenitis supurativa 2017. Ed: Draft Editores, Madrid. ISBN: 978-84-88014-40-5
[3] Ardon CB, Molenaar C, Van Straalen KR, Scholtes VC, Prens EP, Van der Zee HH. High prevalence of hidradenitis suppurativa in patients with perianal fistula. Int J  ColorectalDis 2019;34:1337–1339. 10.1007/s00384-019-03313-2.
[4] Iwadare J, Sumikoshi Y, Ono R, Kohda M, Miyawaki H, Yamamoto K. Periproctal Hidradenitis Suppurativa. J. Jpn Soc. Coloproctol1987;40:813–821.
[5] Thornton JP, Abcarian H. Surgical treatment of perianal and perineal hidradenitis suppurativa. Dis Colon Rectum 1978; 21(8):573–577 

[6] Church JM, Fazio VW, Lavery IC, Oakley JR, Milsom JW. The differential diagnosis and comorbidity of hidradenitis suppurativa and perianal Crohn’s disease. Int J Colorectal Dis 1993;8(3):117–119 

[7] Hurley H. Axillary hyperhidrosis, apocrine bromhidrosis, hidradenitis suppurativa, and familial benign pemphigus: surgical approach. In: Roenigk RK, Roenigk HH (eds) Roenigk and Roenigk’s dermatologic surgery: principles and practice. Marcel Dekker, New York, 1989
[8] Bernal JC, Tárraga J, Gómez L, Cifre C, Melero A, Ivorra P, Gª-Coret MªJ, Salvador A,  Zaragoza C. Is perineal/perianal hidradenitis suppurativa (HS) associated with anal fistula? Colorectal Dis 2019;21(Suppl.3), 33-128
[9] Martorell A, Segura Palacios JM. Ecografía de la hidradenitis supurativa. Actas Dermosifiliogr (106 Suppl) 1:49–59. Martorell, A., & Segura Palacios, J. M. (2015). Ecografía de la hidradenitis supurativa. Actas Dermo-Sifiliográficas, 2015;106, 49–59. doi:10.1016/s0001-7310(16)30007-2 
[10] Wortsman X (2016) Imaging of Hidradenitis Suppurativa. Dermatol Clin  34: 59–68. doi: 10.1016/j.det.2015.08.003
[11] Kolodziejczak M, Sudol-Szopinska I, Wilczynska A, Bierca J. Utility of transperineal and anal ultrasonography in the diagnosis of hidradenitis suppurativa and its differentiation from a rectal fistula. Postepy Hig Med Dosw 2012;66:838-42. doi: 10.5604/17322693.1019537.
[12] Bernal-Sprekelsen JC, López J, Esclápez P, Trullenque R. Fistulectomía tipo Core out modificada. Abordaje personal. Cir Esp 2000; 67:462-465
[13] Monnier L, Dohan A, Amara N, Zagdanski AM, Drame M, Soyer P, Hoeffel C. Anoperineal disease in Hidradenitis Suppurativa : MR imaging distinction from perianal Crohn’s disease. European Radiology 2017;27(10): 4100–4109. doi: 10.1007/s00330-017-4776-1.
[14] Griffin N, Williams AB, Anderson S, Irving PM, Sanderson J, Desai N, Goh V. Hidradenitis Suppurativa. MRI Features in Anogenital Disease. Diseases of the Colon & Rectum 2014;57(6): 762–771. doi: 10.1097/DCR.0000000000000131.
[15] Derruau S, Renard Y, Pron H, Taiar R, Abdi E, Polidori G, Lorimier S.  Combining Magnetic Resonance Imaging (MRI) and Medical Infrared Thermography (MIT) in the pre- and per-operating management of severe Hidradenitis Suppurativa (HS) Photodiagnosis and Photodynamic Therapy  2018;23: 9-11. doi: 10.1016/j.pdpdt.2018.05.007
[16] Scholl L, Hessam S, Bergmann U. Surgical Treatment of Sinus Tracts and Fistulas in Perianal Hidradenitis Suppurativa. Journal of Cutaneous Medicine and Surgery 2018;22(2): 239–241. doi: 10.1177/1203475417746122
[17] Lamb AA, Kennedy NA, Raine T, Hendy PA, Smith PJ, Limdi JK, et al.  British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut 2019;0:1-106. doi: 10.1136/gutjnl-2019-318484
           [18] Williams G, Williams A, Tozer P, Phillips r, Ahmead A, Jayne D, Mawell-Armstrong C. The  
treatment of anal fistula: second ACPGBI Position Statement-2018. Colorectal Dis 2018;20 (Suppl. 3):5-3. doi:10.1111/codi.14054
[19] Herreros MD, García-Olmo D, Guadalajara H, Georgiev-Hristov T, Brandariz L, García-Arranz M.  Stem cell therapy: a compassionate use program in perianal fistula. Hindawi Stem Cells International 2019;1-6; doi.org/10.1155/2019/6132340